Boris Kubuschok

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 6

Top Topics

Epstein Barr Virus

Hodgkin Lymphoma

Diffuse Large B Cell Lymphoma

Top Venues

Annals of hematology

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

Boris Kubuschok, Burkhard Otremba, Manfred Welslau, Julian Topaly, Thomas Wolff, Georg Lenz, Michael Grau, Larissa Bittencourt da Silva, Ines Brückmann, Tobias Foierl
Quality of life assessment in diffuse large B-cell lymphoma (DLBCL) in REFLECT: a prospective, non-interventional, multicenter, German study, assessing Sandoz rituximab in combination with CHOP. Annals of hematology 103 (8) (2024)
Boris Kubuschok, Burkhard Otremba, Manfred Welslau, Julian Topaly, Thomas Wolff, Georg Lenz, Michael Grau, Larissa Bittencourt da Silva, Ines Brückmann, Tobias Foierl
Quality of life assessment in diffuse large B-cell lymphoma (DLBCL) in REFLECT: a prospective, non-interventional, multicenter, German study, assessing Sandoz rituximab in combination with CHOP. Annals of hematology 103 (8) (2024)
Boris Kubuschok, Burkhard Otremba, Manfred Welslau, Julian Topaly, Thomas Wolff, Georg Lenz, Michael Grau, Larissa Bittencourt da Silva, Ines Brückmann, Tobias Foierl
Quality of life assessment in diffuse large B-cell lymphoma (DLBCL) in REFLECT: a prospective, non-interventional, multicenter, German study, assessing Sandoz rituximab in combination with CHOP. Annals of hematology 103 (8) (2024)
Boris Kubuschok, Burkhard Otremba, Manfred Welslau, Julian Topaly, Thomas Wolff, Georg Lenz, Michael Grau, Larissa Bittencourt da Silva, Ines Brückmann, Tobias Foierl
Quality of life assessment in diffuse large B-cell lymphoma (DLBCL) in REFLECT: a prospective, non-interventional, multicenter, German study, assessing Sandoz rituximab in combination with CHOP. Annals of hematology (2024)
Boris Kubuschok, Burkhard Otremba, Manfred Welslau, Julian Topaly, Thomas Wolff, Georg Lenz, Michael Grau, Larissa Bittencourt da Silva, Ines Brückmann, Tobias Foierl
Quality of life assessment in diffuse large B-cell lymphoma (DLBCL) in REFLECT: a prospective, non-interventional, multicenter, German study, assessing Sandoz rituximab in combination with CHOP. Annals of hematology 103 (8) (2024)
Maria Pouyiourou, Bianca N Kraft, Timothy Wohlfromm, Michael Stahl, Boris Kubuschok, Harald Löffler, Ulrich T Hacker, Gerdt Hübner, Lena Weiss, Michael Bitzer, Thomas Ernst, Philipp Schütt, Thomas Hielscher, Stefan Delorme, Martina Kirchner, Daniel Kazdal, Markus Ball, Klaus Kluck, Albrecht Stenzinger, Tilmann Bochtler, Alwin Krämer
Nivolumab and ipilimumab in recurrent or refractory cancer of unknown primary: a phase II trial. Nature communications 14 (1) (2023)